Reported Earlier, 'New Mpox Variant Detected In Germany: Health Authority' - The Economic Times
INOVIO Presents Data on INO-3107's Immune Response Against HPV-6 and HPV-11
Express News | Inovio Pharmaceuticals Inc - Ino-3107 Well Tolerated, 81% of Patients Required Fewer Surgeries Post-Treatment
Express News | Inovio Announces New Data at Scientific Conferences for Lead Candidate, Ino-3107, as a Potential Treatment for Rrp
Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?
Inovio Pharma Is Maintained at Sector Perform by RBC Capital